Hotchkis & Wiley Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,800
| Closed | -$481K | – | 500 |
|
|
2022
Q3 | $481K | Buy |
1,800
+200
| +13% | +$53.4K | ﹤0.01% | 507 |
|
|
2022
Q2 | $326K | Hold |
1,600
| – | – | ﹤0.01% | 487 |
|
|
2022
Q1 | $337K | Hold |
1,600
| – | – | ﹤0.01% | 482 |
|
|
2021
Q4 | $384K | Hold |
1,600
| – | – | ﹤0.01% | 486 |
|
|
2021
Q3 | $453K | Hold |
1,600
| – | – | ﹤0.01% | 474 |
|
|
2021
Q2 | $554K | Sell |
1,600
-197,311
| -99% | -$68.3M | ﹤0.01% | 463 |
|
|
2021
Q1 | $55.6M | Sell |
198,911
-500
| -0.3% | -$140K | 0.17% | 87 |
|
|
2020
Q4 | $48.8M | Sell |
199,411
-4,900
| -2% | -$1.2M | 0.17% | 85 |
|
|
2020
Q3 | $58M | Sell |
204,311
-75,060
| -27% | -$21.3M | 0.26% | 70 |
|
|
2020
Q2 | $74.7M | Sell |
279,371
-100
| -0% | -$26.8K | 0.35% | 63 |
|
|
2020
Q1 | $88.4M | Buy |
279,471
+8,000
| +3% | +$2.53M | 0.5% | 53 |
|
|
2019
Q4 | $80.6M | Buy |
271,471
+33,399
| +14% | +$9.91M | 0.28% | 74 |
|
|
2019
Q3 | $55.4M | Buy |
238,072
+200
| +0.1% | +$46.6K | 0.22% | 85 |
|
|
2019
Q2 | $55.6M | Sell |
237,872
-2,500
| -1% | -$585K | 0.21% | 83 |
|
|
2019
Q1 | $56.8M | Sell |
240,372
-4,200
| -2% | -$993K | 0.22% | 88 |
|
|
2018
Q4 | $73.6M | Sell |
244,572
-8,600
| -3% | -$2.59M | 0.32% | 72 |
|
|
2018
Q3 | $89.4M | Sell |
253,172
-9,900
| -4% | -$3.5M | 0.32% | 73 |
|
|
2018
Q2 | $76.4M | Sell |
263,072
-4,600
| -2% | -$1.34M | 0.29% | 74 |
|
|
2018
Q1 | $73.3M | Sell |
267,672
-4,000
| -1% | -$1.1M | 0.29% | 73 |
|
|
2017
Q4 | $86.5M | Sell |
271,672
-3,100
| -1% | -$988K | 0.33% | 71 |
|
|
2017
Q3 | $86M | Sell |
274,772
-11,800
| -4% | -$3.69M | 0.34% | 70 |
|
|
2017
Q2 | $77.8M | Hold |
286,572
| – | – | 0.31% | 71 |
|
|
2017
Q1 | $78.4M | Sell |
286,572
-228
| -0.1% | -$62.3K | 0.31% | 72 |
|
|
2016
Q4 | $81.3M | Sell |
286,800
-19,300
| -6% | -$5.47M | 0.33% | 74 |
|
|
2016
Q3 | $95.8M | Buy |
306,100
+77,100
| +34% | +$24.1M | 0.4% | 64 |
|
|
2016
Q2 | $55.4M | Buy |
+229,000
| New | +$55.4M | 0.24% | 90 |
|